Pheochromocytoma secondary prevention
|
Pheochromocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pheochromocytoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Pheochromocytoma secondary prevention |
|
Risk calculators and risk factors for Pheochromocytoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Secondary Prevention
- Preoperative treatment of pheochromocytoma is the best way to reduce complications and improve morbidity by controlling hypertension during surgery and hypotension after it.
All patients with pheochromoctoma need postoperative follow up:
- Patients should undergo baseline postoperative biochemical testing and annual lifelong tests.[1]
- Noncatecholamine-producing tumor should undergo annual imaging with CT or MRI to monitor for recurrence.[2]
Genetic testing should be performed in:[2]
- Patients with a family history of pheochromocytoma
- Bilateral or multifocal lesions
- Tumors or malignant or extra-adrenal pheochromocytoma
- Young patients who are aged 50 years or under
References
- ↑ Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004). "Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan". Hypertens Res. 27 (3): 193–202. PMID 15080378.
- ↑ Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004). "Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan". Hypertens Res. 27 (3): 193–202. PMID 15080378.